---
bio: I am a clinical pharmacist and an Associate Professor of Infectious Diseases in the Department of Medical and Surgical Sciences as the University of Bologna. I have over 20 years experience in laboratory and clinical research of antimicrobial pharmacokinetics and pharmacodynamics in immunocompromised hosts. My current research focuses on the development of prognostic risk models and decision support tools for the diagnosis and treatment of fungal infections and multidrug resistant bacteria.
  matter.
education:
  courses:
  - course: Doctor of Clinical Pharmacy (Pharm.D.) 
    institution: University of Kansas, Lawrence, Kansas
    year: 1996
  - course: Clinical Pharmacy Residency
    institution: Barnes-Jewish Hospital, St. Louis, Missouri
    year: 1997
  - course: Infectious Diseases Research Fellowship
    institution: University of Iowa Colleges of Pharmacy and Medicine
    year: 1998-1999
email: "russeledward.lewis@unibo.it"
highlight_name: true
interests:
- Antimicrobial pharmacokinetics/pharmacodynamics
- Immunocompromised hosts
- Prognostic models and decision (dosing) support tools
organizations:
- name: Alma Mater Studiorum Universit√† di Bologna
  url: https://www.unibo.it/sitoweb/russeledward.lewis
role: Associate Professor of Infectious Diseases (MED/17)
social:
- icon: envelope
  icon_pack: fas
  link: /#contact
- display:
    header: true
  icon: twitter
  icon_pack: fab
  label: Follow me on Twitter
  link: https://twitter.com/Russlewis_
- icon: graduation-cap
  icon_pack: fas
  link: https://scholar.google.com/citations?user=5mYwM2gAAAAJ&hl=en
- icon: github
  icon_pack: fab
  link: https://github.com/Russlewisbo
- icon: linkedin
  icon_pack: fab
  link: https://www.linkedin.com/in/russell-lewis-64943589/
superuser: true
title: Russell E. Lewis
---
Russell Lewis is clinical pharmacologist and Associate Professor of Infectious Diseases in the Department of Medical and Surgical Sciences as the University of Bologna. He has over 20 years experience in laboratory and clinical research of antimicrobial pharmacokinetics and pharmacodynamics in immunocompromised hosts. His current research focuses on the development of prognostic risk models and decision support tools for the diagnosis and treatment of fungal infections and multidrug resistant bacteria infections.


{{< icon name="download" pack="fas" >}} Download my {{< staticref "uploads/resume.pdf" "newtab" >}}curriculum vitae{{< /staticref >}}.
